Form 4: Tandem Diabetes Care EVP Leigh Vosseller Reports Stock Transactions
SEC Form 4
EVP and CFO of Tandem Diabetes Care, Leigh Vosseller, reports acquisition and disposal of company stock and restricted stock units (RSUs) on May 15, 2025.
Summary
- Leigh Vosseller, EVP & CFO of Tandem Diabetes Care, filed a Form 4 detailing changes in beneficial ownership of the company's stock.
- On May 15, 2025, Vosseller acquired 1,359 shares of common stock through the Employee Stock Purchase Plan at $15.64 per share.
- Vosseller also acquired shares through the vesting of restricted stock units (RSUs).
- A total of 8,121 shares were acquired through RSU vesting at a price of $0.
- Shares were withheld to cover tax obligations related to the vesting of RSUs, with 58, 170, 538, and 2,141 shares withheld at $22.7 per share.
- Following these transactions, Vosseller directly owns 33,798 shares and indirectly owns 11,860 shares through the Leigh A. Vosseller Trust.
Sentiment
Score: 5
Explanation: This is a neutral report on stock transactions by an executive. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Positives
- The acquisition of shares through the Employee Stock Purchase Plan indicates Vosseller's investment in the company's future.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It provides transparency into the executive's holdings and transactions in the company's stock.
Comparison to Industry Standards
- Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders.
- Vesting schedules for RSUs are typical, designed to incentivize long-term commitment from executives.
- Tax withholding on vesting RSUs is a standard practice.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect an executive's trading activity.
Key Dates
| Date | Description |
|---|---|
| January 17, 2010 | Date of the Leigh A. Vosseller Trust |
| May 18, 2021 | Date of RSU award pursuant to the 2013 Plan |
| May 25, 2022 | Date of RSU award pursuant to the 2013 Plan |
| May 25, 2023 | Date of RSU award pursuant to the 2023 Plan |
| May 23, 2024 | Date of RSU award pursuant to the 2023 Plan |
| November 18, 2024 | Start date of ESPP purchase period |
| May 15, 2025 | Date of reported transactions, end date of ESPP purchase period, and vesting date for multiple RSU awards |
| May 19, 2025 | Date of signature on the Form 4 filing |
Keywords
Tandem Diabetes Care, TNDM, Leigh Vosseller, Form 4, Stock, Restricted Stock Units, Beneficial Ownership, Employee Stock Purchase Plan, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.